The cells sense amino acids the building blocks of protein and then release GLP-1 into the bloodstream
in vivo , intra-articular injection (50 M) achieves higher local bioavailability than oral administration (200 mg/kg/d), more effectively restoring MQC and reducing pro-inflammatory cytokines (e.g., IL-1) in OA models (11)
Low glutathione = less defense against inflammation, toxins, and cellular damage the exact opposite of what someone who's already sick needs
Exenatide: Also used in 2 studies, reflecting ongoing exploration of various GLP-1 options
And an even more powerful medication called retatrutide is being tested now and could receive FDA approval in 2027
Sustaining the engine: mitochondrial quality control and transport networks As the central engine of cellular bioenergetics and intermediary metabolism, mitochondrial functional integrity is critical for sustaining high metabolic flux, anabolic potential, and therapeutic responsiveness in CRC [18]